554 related articles for article (PubMed ID: 31717806)
1. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
Aladdin A; Király R; Boto P; Regdon Z; Tar K
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
[TBL] [Abstract][Full Text] [Related]
2. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
[TBL] [Abstract][Full Text] [Related]
3. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.
Lin L; Jin Z; Tan H; Xu Q; Peng T; Li H
Brain Res; 2016 Jul; 1643():103-12. PubMed ID: 27107943
[TBL] [Abstract][Full Text] [Related]
4. VCP cooperates with UBXD1 to degrade mitochondrial outer membrane protein MCL1 in model of Huntington's disease.
Guo X; Qi X
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):552-559. PubMed ID: 27913212
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitin ligase UBR5 suppresses proteostasis collapse in pluripotent stem cells from Huntington's disease patients.
Koyuncu S; Saez I; Lee HJ; Gutierrez-Garcia R; Pokrzywa W; Fatima A; Hoppe T; Vilchez D
Nat Commun; 2018 Jul; 9(1):2886. PubMed ID: 30038412
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington's disease patients.
Jędrak P; Mozolewski P; Węgrzyn G; Więckowski MR
Metab Brain Dis; 2018 Dec; 33(6):2005-2017. PubMed ID: 30120672
[TBL] [Abstract][Full Text] [Related]
7. Mutant huntingtin inhibits the mitochondrial unfolded protein response by impairing ABCB10 mRNA stability.
Fu Z; Liu F; Liu C; Jin B; Jiang Y; Tang M; Qi X; Guo X
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1428-1435. PubMed ID: 30802639
[TBL] [Abstract][Full Text] [Related]
8. Proteasome activator enhances survival of Huntington's disease neuronal model cells.
Seo H; Sonntag KC; Kim W; Cattaneo E; Isacson O
PLoS One; 2007 Feb; 2(2):e238. PubMed ID: 17327906
[TBL] [Abstract][Full Text] [Related]
9. Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients.
Seo H; Kim W; Isacson O
Hum Mol Genet; 2008 Oct; 17(20):3144-53. PubMed ID: 18640989
[TBL] [Abstract][Full Text] [Related]
10. Trehalose reverses cell malfunction in fibroblasts from normal and Huntington's disease patients caused by proteosome inhibition.
Fernandez-Estevez MA; Casarejos MJ; López Sendon J; Garcia Caldentey J; Ruiz C; Gomez A; Perucho J; de Yebenes JG; Mena MA
PLoS One; 2014; 9(2):e90202. PubMed ID: 24587280
[TBL] [Abstract][Full Text] [Related]
11. Targeting the proteostasis network in Huntington's disease.
Soares TR; Reis SD; Pinho BR; Duchen MR; Oliveira JMA
Ageing Res Rev; 2019 Jan; 49():92-103. PubMed ID: 30502498
[TBL] [Abstract][Full Text] [Related]
12. MnFe
Zhang L; Wei PF; Song YH; Dong L; Wu YD; Hao ZY; Fan S; Tai S; Meng JL; Lu Y; Xue J; Liang CZ; Wen LP
Biomaterials; 2019 Sep; 216():119248. PubMed ID: 31226569
[TBL] [Abstract][Full Text] [Related]
13. Bypassing mitochondrial defects rescues Huntington's phenotypes in Drosophila.
Campesan S; Del Popolo I; Marcou K; Straatman-Iwanowska A; Repici M; Boytcheva KV; Cotton VE; Allcock N; Rosato E; Kyriacou CP; Giorgini F
Neurobiol Dis; 2023 Sep; 185():106236. PubMed ID: 37495179
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease.
Yin X; Manczak M; Reddy PH
Hum Mol Genet; 2016 May; 25(9):1739-53. PubMed ID: 26908605
[TBL] [Abstract][Full Text] [Related]
15. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin.
Tanaka A; Cleland MM; Xu S; Narendra DP; Suen DF; Karbowski M; Youle RJ
J Cell Biol; 2010 Dec; 191(7):1367-80. PubMed ID: 21173115
[TBL] [Abstract][Full Text] [Related]
16. Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts.
Rakovic A; Grünewald A; Kottwitz J; Brüggemann N; Pramstaller PP; Lohmann K; Klein C
PLoS One; 2011 Mar; 6(3):e16746. PubMed ID: 21408142
[TBL] [Abstract][Full Text] [Related]
17. Polyglutamine tracts regulate beclin 1-dependent autophagy.
Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC
Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Mitofusin1 by Mahogunin Ring Finger-1 and the proteasome modulates mitochondrial fusion.
Mukherjee R; Chakrabarti O
Biochim Biophys Acta; 2016 Dec; 1863(12):3065-3083. PubMed ID: 27713096
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease.
Quintanilla RA; Jin YN; von Bernhardi R; Johnson GV
Mol Neurodegener; 2013 Dec; 8():45. PubMed ID: 24330821
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of p38 Mitogen-Activated Protein Kinase Ameliorates HAP40 Depletion-Induced Toxicity and Proteasomal Defect in Huntington's Disease Model.
Huang ZN; Chen JM; Huang LC; Fang YH; Her LS
Mol Neurobiol; 2021 Jun; 58(6):2704-2723. PubMed ID: 33492644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
